Pomalidomide Capsules 2 mg, 4 mg, 3 mg, and 4 mg Suppliers & Bulk Manufacturers
Available Forms: capsules.
Available Strengths: 2 mg, 4 mg, 3 mg, and 4 mg
Reference Brands: Talquetamide(US), Pomalyst(EU)
Category: Orphan Drugs
Pomalidomide is an immunomodulatory drug that enhances immune response and inhibits tumor growth by modulating cytokine production and stimulating T-cell activity. It effectively treats refractory multiple myeloma, improving survival, decreasing tumor burden, and supporting long-term disease control while supporting immune health.
Product Description: Pomalidomide capsules, marketed as Pomalyst, are approved in the US by the FDA and in the EU via EMA for relapsed and refractory multiple myeloma. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data to ensure safety and effectiveness, while the EMA evaluates compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and widespread availability, helping improve long-term outcomes for multiple myeloma patients worldwide.
Pomalidomide Capsules — third party manufacturing & bulk supply
Pomalidomide Capsules 2 mg, 4 mg, 3 mg, and 4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Pomalidomide Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Pomalidomide Capsules →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
